Journal of Medicinal Chemistry · 2007 · 194 citations · 6 references
PharmacyMedicinal ChemistryPharmacologyApoptosisDrug DiscoveryStructure-activity RelationshipsApoptosis In CancerApoptosis PharmacologyHeterocyclic ChemistryAnti-apoptotic AgentsAromatic Ring FeaturesAromatic Ring ReplacementChemical Structure-activity RelationshipsFused Ring ModificationMedicinal HeterocyclesTubulin Polymerization Inhibitors
As a continuation of our efforts to discover and develop the apoptosis-inducing 4-aryl-4H-chromenes as novel anticancer agents, we explored the SAR of fused rings at the 7,8-positions. It was found that a five-member aromatic ring, such as pyrrolo with nitrogen at either the 7- or 9-position, is preferred. A six-member aromatic ring, such as benzo or pyrido, also led to potent compounds. The SAR of the 4-aryl group was found to be similar for chromenes with a fused ring at the 7,8-positions. These compounds were found to inhibit tubulin polymerization, indicating that cyclization of the 7,8-positions into a ring does not change the mechanism of action. Compound 2h was identified to be a highly potent apoptosis inducer with an EC50 of 5 nM and a highly potent inhibitor of cell proliferation with a GI50 of 8 nM in T47D cells.
6
Henriette Gourdeau, Lorraine Leblond, Bettina A. Hamelin et al. · Molecular Cancer Therapeutics · 2004 · 289 citations
William Kemnitzer, John Drewe, Songchun Jiang et al. · Journal of Medicinal Chemistry · 2004 · 279 citations
William Kemnitzer, Shailaja Kasibhatla, Songchun Jiang et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 273 citations · Full text
Stephen J. Haggarty, Thomas U. Mayer, David T. Miyamoto et al. · Chemistry & Biology · 2000 · 250 citations · Full text